Results 91 to 100 of about 22,621 (200)

Osteoarticular Candida Infection: Report of Three Cases and Literature Review of 44 Patients

open access: yesMediterranean Journal of Infection, Microbes and Antimicrobials, 2019
Fungal infections in the bones and joints are rare. Candida spp. osteomyelitis is also a very rare entity. The most common pathogen is Candida albicans, but an increase in the incidence of non-albicans Candida osteomyelitis has been reported in recent ...
Firdevs AKSOY   +8 more
doaj   +1 more source

Cell wall perturbation sensitizes fungi to the antimalarial drug chloroquine. [PDF]

open access: yes, 2013
Journal ArticleResearch Support, Non-U.S. Gov'tCopyright © 2015 by the American Society for Microbiology.Post print version deposited in accordance with SHERPA RoMEO guidelines.Chloroquine (CQ) has been a mainstay of antimalarial drug treatment for ...
Avery, SV   +5 more
core   +5 more sources

MIC Distributions and Evaluation of Fungicidal Activity for Amphotericin B, Itraconazole, Voriconazole, Posaconazole and Caspofungin and 20 Species of Pathogenic Filamentous Fungi Determined Using the CLSI Broth Microdilution Method

open access: yesJournal of Fungi, 2017
For filamentous fungi (moulds), species-specific interpretive breakpoints and epidemiological cut-off values (ECVs) have only been proposed for a limited number of fungal species–antifungal agent combinations, with the result that clinical breakpoints ...
Andrew M. Borman   +6 more
doaj   +1 more source

Caspofungin for prevention of intra-abdominal candidiasis in high-risk surgical patients [PDF]

open access: yes, 2018
Purpose: Thirty to forty percent of patients with recurrent gastrointestinal perforation/anastomotic leakage or acute necrotizing pancreatitis develop intra-abdominal invasive candidiasis (IC).
Bille, Jacques   +7 more
core  

Disseminated Invasive Aspergillosis with Cerebral Involvement Successfully Treated with Caspofungin and Voriconazole [PDF]

open access: yes, 2018
We describe a case of cerebral aspergillosis which was successfully treated with a combination of caspofungin and voriconazole. The patient remains in remission 18 months after stopping antifungal treatment.
Gubler, C.   +4 more
core  

Caspofungin versus anidulafungin in patients with invasive candidiasis: a retrospective study with propensity-score-matched analysis

open access: yesTherapeutic Advances in Infectious Disease
Background: Echinocandins are recommended as an initial treatment for invasive candidiasis. Although safety and efficacy profiles of both anidulafungin and caspofungin are well established, direct head-to-head comparisons have not been reported before ...
Reem Hasan Elajez   +10 more
doaj   +1 more source

Comparison of Vitek 2C antifungal susceptibility testing with broth microdilution testing for Candida species [PDF]

open access: yesMedical Laboratory Journal
Background: The reference method for antifungal susceptibility testing is broth microdilution according to Clinical and Laboratory Standard Institute (CLSI) guidelines.
Sukanya Sudhaharan   +2 more
doaj  

Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America [PDF]

open access: yes, 2017
Guidelines for the management of patients with invasive candidiasis and mucosal candidiasis were prepared by an Expert Panel of the Infectious Diseases Society of America.
Andes, David   +13 more
core  

Rezafungin Versus Caspofungin for the Treatment of Candidemia and Invasive Candidiasis: Results from the Double-blind, Randomized, Phase 3 ReSTORE Trial Including the China Extension Study. [PDF]

open access: yesOpen Forum Infect Dis
Thompson GR   +12 more
europepmc   +1 more source

A screen to identify antifungal antagonists reveals a variety of pharmacotherapies that induce echinocandin tolerance in <i>Candida albicans</i>. [PDF]

open access: yesAntimicrob Agents Chemother
Reitler P   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy